The role of MiR-146a in respiratory diseases with a focus on COVID-19

alipour, shahriar; Hamad Khdhir, Karmand

doi:https://doi.org/10.61882/umj.36.4.6

Volume 36, Issue 4 (12-2025) Studies in Medical Sciences 2025, 36(4): 6-21 | Back to browse issues page

‎ https://doi.org/10.61882/umj.36.4.6

Mendeley

Zotero

RefWorks

alipour S, Hamad Khdhir K. The role of MiR-146a in respiratory diseases with a focus on COVID-19. Studies in Medical Sciences 2025; 36 (4) :6-21
URL: http://umj.umsu.ac.ir/article-1-6507-en.html

The role of MiR-146a in respiratory diseases with a focus on COVID-19

Shahriar Alipour ^*

, Karmand Hamad Khdhir

Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran. , alipourshahriar17@gmail.com

Abstract: (15 Views)

Epigenetics is a rapidly expanding scientific discipline, and research into epigenetic regulation in diseases, including infectious diseases, is increasing. As one sort of epigenetic activity, micro-ribonucleic acids (miRNAs) bind to their target messenger RNAs (mRNAs) and regulate their stability and/or translation. This study aims to evaluate non-coding RNAs (ncRNAs) with a focus on miR-146a in COVID-19. In this review, we first describe epigenetics and miRNAs, then explain the significance of miRNAs in disease, with an emphasis on lung diseases. Finally, we examine the role of miRNAs in viral infections, including SARS-CoV-2, with a particular focus on miR-146a. For all relevant studies published between 2000 and 2022, a systematic search of PubMed, Web of Science, Embase, and the Cochrane Library was conducted, limited to English-language studies. Studies were included if they were published between 2000 and 2022, written in English, and directly addressed miR-146a expression or function in respiratory or inflammatory diseases. Non-peer-reviewed sources and studies lacking primary data on miR-146a were excluded. The findings revealed that different types of microRNAs can be useful in the therapy of various lung diseases via different target pathways and genes. Among these, miR-146a has emerged as a key regulator of innate immunity and inflammatory responses in respiratory diseases. miR-146a regulates IL-18 production through modulation of the NF-κB signaling pathway by targeting IRAK1 and TRAF6, which may influence inflammatory responses in severe COVID-19. Furthermore, dysregulation of miR-146a has been associated with enhanced inflammatory responses and disease severity in respiratory viral infections. These findings suggest that miR-146a may serve as a promising biomarker for disease prognosis and a potential therapeutic target in COVID-19 and other respiratory diseases. However, further experimental and clinical studies are required to validate its diagnostic and therapeutic value.

Keywords: COVID-19, Epigenetics, MicroRNAs, MiR-146a, Respiratory diseases

Full-Text [PDF 671 kb] (4 Downloads)

Type of Study: Review article | Subject: ویروس شناسی

References

1. Menachery VD, Schäfer A, Burnum-Johnson KE, Mitchell HD, Eisfeld AJ, Walters KB, et al. MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape. Proceedings of the National Academy of Sciences. 2018; 115(5):E1012-21.doi: 10.1073/pnas.1706928115. [DOI:10.1073/pnas.1706928115] [PMID] [PMCID]

2. Konigsberg IR, Barnes B, Campbell M, Davidson E, Zhen Y, Pallisard O, et al. Host methylation predicts SARS-CoV-2 infection and clinical outcome. Commun Med. 2021;1(1):42.doi: 10.1038/s43856-021-00042-y. [DOI:10.1038/s43856-021-00042-y] [PMID] [PMCID]

3. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006;31(2):89-97.doi: 10.1016/j.tibs.2005.12.008. [DOI:10.1016/j.tibs.2005.12.008] [PMID]

4. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006; 6(2) :107-16.doi: 10.1038/nrc1799. [DOI:10.1038/nrc1799] [PMID]

5. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350-5.doi: 10.1038/nature02871. [DOI:10.1038/nature02871] [PMID]

6. Wang J, Chen J, Sen S. MicroRNA as Biomarkers and Diagnostics. J Cell Physiol . 2016;231(1):25-30. doi: 10.1002/jcp.25056. [DOI:10.1002/jcp.25056] [PMID] [PMCID]

7. O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of action, and circulation. Front Endocrinol (Lausanne). 2018;9(5):402. doi: 10.3389/fendo.2018.00402. [DOI:10.3389/fendo.2018.00402] [PMID] [PMCID]

8. Liu Z, Wang J, Xu Y, Guo M, Mi K, Xu R, et al. Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2 [Preprint]. arXiv. 2020:arXiv:2004.04874. [GOOGLE SCHOLAR]

9. Sodagar H, Alipour S, Hassani S, Ghaleh Aziz SG, Ansari MHK, Asghari R. The role of microRNAs in COVID-19 with a focus on miR-200c. J Circ biomark. 2022;11(1):14-23.doi: 10.33393/jcb.2022.2356. [DOI:10.33393/jcb.2022.2356] [PMID] [PMCID]

10. Steiner S, Kratzel A, Barut GT, Lang RM, Moreira EA, Thomann L, et al. SARS-CoV-2 biology and host interactions. Nat Rev Microbiol. 2024;22(4):206-225. doi:10.1038/s41579-023-01003-z [DOI:10.1038/s41579-023-01003-z] [PMID]

11. Xie M, Liu X, Cao X, Guo M, Li X. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respir Res. 2020;21(1):49. doi: 10.1186/s12931-020-1291-8. [DOI:10.1186/s12931-020-1291-8] [PMID] [PMCID]

12. Sessa R, Hata A. Role of microRNAs in lung development and pulmonary diseases. Pulm Circ.; 2013; 3(2):315-28. doi: 10.4103/2045-8932.114758. [DOI:10.4103/2045-8932.114758] [PMID] [PMCID]

13. Tomankova T, Petrek M, Kriegova E. Involvement of microRNAs in physiological and pathological processes in the lung. Respir Res . 2010;11(1):159 .doi: 10.1186/1465-9921-11-159. [DOI:10.1186/1465-9921-11-159] [PMID] [PMCID]

14. Rodriguez A, Vigorito E, Clare S, Warren M V, Couttet P, Soond DR, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316(5824):608-11.doi: 10.1126/science.1139253. [DOI:10.1126/science.1139253] [PMID] [PMCID]

15. Abd-El-Fattah AA, Sadik NA, Shaker OG, Aboulftouh ML. Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. Cell Biochem Biophys .2013 ;67(3):875-84.doi: 10.1007/s12013-013-9575-y. [DOI:10.1007/s12013-013-9575-y] [PMID]

16. Sodagar H, Khadem Ansari MH, Asghari R, Alipour S. Evaluation of Serum Levels of MicroRNA-200C and ACE2 Gene Expression in Severe and Mild Phases of Patients with COVID-19. Iran J Allergy Asthma Immunol. 2022;21(3) :254-62.doi: 10.18502/ijaai.v21i3.9799. [DOI:10.18502/ijaai.v21i3.9799] [PMID]

17. Mallick B, Ghosh Z, Chakrabarti J. MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells. PLoS One. 2009;4(11) :e7837.doi: 10.1371/journal.pone.0007837. [DOI:10.1371/journal.pone.0007837] [PMID] [PMCID]

18. Martinez-Nunez RT, Louafi F, Sanchez-Elsner T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem. 2011;286(3):1786-94. doi: 10.1074/jbc.M110.169367. [DOI:10.1074/jbc.M110.169367] [PMID] [PMCID]

19. Martinez-Nunez RT, Louafi F, Sanchez-Elsner T. The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor α1 (IL13Rα1). J Biol Chem. 2011;286(3):1786-94.doi: 10.1074/jbc.M110.169367. [DOI:10.1074/jbc.M110.169367] [PMID] [PMCID]

20. Collison A, Mattes J, Plank M, Foster PS. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol. 2011;128(1):160-7.e4. doi: 10.1016/j.jaci.2011.04.005. [DOI:10.1016/j.jaci.2011.04.005] [PMID] [PMCID]

21. Sessa R, Hata A. Role of microRNAs in lung development and pulmonary diseases. Pulm Circ. 2013;3(2):315-28.doi: 10.4103/2045-8932.114758. [DOI:10.4103/2045-8932.114758] [PMID] [PMCID]

22. Polikepahad S, Knight JM, Naghavi AO, Oplt T, Creighton CJ, Shaw C, et al. Proinflammatory Role for let-7 MicroRNAS in Experimental Asthma. J Biol Chem. 2010;285(39):30139-49. doi: 10.1074/jbc.M110.145698. [DOI:10.1074/jbc.M110.145698] [PMID] [PMCID]

23. Chiba Y, Tanabe M, Goto K, Sakai H, Misawa M. Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am J Respir Crit Care Med. 2009;180(8):713-9. doi: 10.1164/rccm.200903-0325OC. [DOI:10.1164/rccm.200903-0325OC] [PMID]

24. Lee HY, Lee HY, Choi JY, Hur J, Kim IK, Kim YK, et al. Inhibition of MicroRNA-21 by an antagomir ameliorates allergic inflammation in a mouse model of asthma. Exp Lung Res. 2017;43(3):109-19. doi: 10.1080/01902148.2017.1304465. [DOI:10.1080/01902148.2017.1304465] [PMID]

25. Li JJ, Tay HL, Maltby S, Xiang Y, Eyers F, Hatchwell L, et al. MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity. J Allergy Clin Immunol. 2015;136(2):462-73. doi: 10.1016/j.jaci.2014.11.044. [DOI:10.1016/j.jaci.2014.11.044] [PMID]

26. Cushing L, Kuang P, Lü J. The role of miR-29 in pulmonary fibrosis. Biochem Cell Biol. 2015;93(2):109-18.doi: 10.1139/bcb-2014-0095. [DOI:10.1139/bcb-2014-0095] [PMID]

27. Montgomery RL, Yu G, Latimer PA, Stack C, Robinson K, Dalby CM, et al. MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol Med. 2014;6(10):1347-56. doi: 10.15252/emmm.201303604. [DOI:10.15252/emmm.201303604] [PMID] [PMCID]

28. Herrera J, Beisang DJ, Peterson M, Forster C, Gilbertsen A, Benyumov A, et al. Dicer1 deficiency in the idiopathic pulmonary fibrosis fibroblastic focus promotes fibrosis by suppressing MicroRNA biogenesis. Am J Respir Crit Care Med. 2018;198(4):486-96. doi: 10.1164/rccm.201709-1823OC. [DOI:10.1164/rccm.201709-1823OC] [PMID] [PMCID]

29. Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y, et al. The Antifibrotic Effects and Mechanisms of MicroRNA-26a Action in Idiopathic Pulmonary Fibrosis. Mol Ther. 2014;22(6):1122-33. doi: 10.1038/mt.2014.42. [DOI:10.1038/mt.2014.42] [PMID] [PMCID]

30. Liang H, Gu Y, Li T, Zhang Y, Huangfu L, Hu M, et al. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Cell Death Dis. 2014;5(5):e1238.doi: 10.1038/cddis.2014.207. [DOI:10.1038/cddis.2014.207] [PMID] [PMCID]

31. Sodagar H, Alipour S, Hassani S, Gholizadeh-Ghaleh Aziz S, Khadem Ansari MH, Asghari R. The role of microRNAs in COVID-19 with a focus on miR-200c. J Circ Biomark. 2022;11:14-23. doi:10.33393/JCB.2022.2356. [DOI:10.33393/jcb.2022.2356] [PMID] [PMCID]

32. Liu B, Li R, Zhang J, Meng C, Zhang J, Song X, et al. MicroRNA-708-3p as a potential therapeutic target via the ADAM17-GATA/STAT3 axis in idiopathic pulmonary fibrosis. Exp Mol Med 2018;50(3):e465. doi: 10.1038/emm.2017.311. [DOI:10.1038/emm.2017.311] [PMID] [PMCID]

33. Pandit K V, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;182(2):220-9. doi: 10.1164/rccm.200911-1698OC. [DOI:10.1164/rccm.200911-1698OC] [PMID] [PMCID]

34. Yang G, Yang L, Wang W, Wang J, Wang J, Xu Z. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression. Gene. 2015;562(1):138-44. doi: 10.1016/j.gene.2015.02.065. [DOI:10.1016/j.gene.2015.02.065] [PMID] [PMCID]

35. Chen BB, Li ZH, Gao S. Circulating miR-146a/b correlates with inflammatory cytokines in COPD and could predict the risk of acute exacerbation COPD. Medicine (Baltimore) .2018;97(7) :e9820. doi: 10.1097/MD.0000000000009820. [DOI:10.1097/MD.0000000000009820] [PMID] [PMCID]

36. Sato T, Liu X, Nelson A, Nakanishi M, Kanaji N, Wang X, et al. Reduced miR-146a increases prostaglandin E₂in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2010;182(8):1020-9.doi: 10.1164/rccm.201001-0055OC. [DOI:10.1164/rccm.201001-0055OC] [PMID] [PMCID]

37. Gu W, Yuan Y, Yang H, Wu H, Wang L, Tang Z, et al. Role of miR-195 in cigarette smoke-induced chronic obstructive pulmonary disease. Int Immunopharmacol. 2018;55:49-54. doi: 10.1016/j.intimp.2017.11.030. [DOI:10.1016/j.intimp.2017.11.030] [PMID]

38. Nouws J, Wan F, Finnemore E, Roque W, Kim SJ, Bazan I, et al. MicroRNA miR-24-3p reduces DNA damage responses, apoptosis, and susceptibility to chronic obstructive pulmonary disease. JCI Insight. 2021;6(2) :e134218. doi: 10.1172/jci.insight.134218. [DOI:10.1172/jci.insight.134218] [PMID] [PMCID]

39. Alshalalfa M, Alhajj R. Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures. BMC Bioinformatics. 2013;14 Suppl 12(Suppl 12) :S1.doi: 10.1186/1471-2105-14-S12-S1. [DOI:10.1186/1471-2105-14-S12-S1] [PMID] [PMCID]

40. Song J, Wang QH, Zou SC. Role of microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci. 2018;22(13):4319-24. doi:10.26355/eurrev_201807_15428. [GOOGLE SCHOLAR]

41. Dang X, Qu X, Wang W, Liao C, Li Y, Zhang X, et al. Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease. Respir Res. 2017;18(1):4. doi: 10.1186/s12931-016-0486-5. [DOI:10.1186/s12931-016-0486-5] [PMID] [PMCID]

42. Oglesby IK, Bray IM, Chotirmall SH, Stallings RL, O'Neill SJ, McElvaney NG, et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol. 2010;184(4):1702-9. doi: 10.4049/jimmunol.0902669. [DOI:10.4049/jimmunol.0902669] [PMID]

43. Sonneville F, Ruffin M, Coraux C, Rousselet N, Le Rouzic P, Blouquit-Laye S, et al. MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology. Nat Commun. 2017;8(1):710.doi: 10.1038/s41467-017-00813-z. [DOI:10.1038/s41467-017-00813-z] [PMID] [PMCID]

44. Ramachandran S, Karp PH, Jiang P, Ostedgaard LS, Walz AE, Fisher JT, et al. A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutant cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A. 2012;109(33):13362-7. doi: 10.1073/pnas.1210906109. [DOI:10.1073/pnas.1210906109] [PMID] [PMCID]

45. Gillen AE, Gosalia N, Leir SH, Harris A. microRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. Biochem J. 2011;438(1):25-32. doi: 10.1042/BJ20110672. [DOI:10.1042/BJ20110672] [PMID] [PMCID]

46. Li WT, Zhang Q. MicroRNA-708-5p regulates mycobacterial vitality and the secretion of inflammatory factors in Mycobacterium tuberculosis-infected macrophages by targeting TLR4. Eur Rev Med Pharmacol Sci. 2019;23(18):8028-38. [GOOGLE SCHOLAR]

47. Guo Z, Cai X, Guo X, Xu Y, Gong J, Li Y, et al. Let-7b ameliorates Crohn's disease-associated adherent-invasive E coli induced intestinal inflammation via modulating Toll-Like Receptor 4 expression in intestinal epithelial cells. Biochem Pharmacol. 2018;156:196-203. doi: 10.1016/j.bcp.2018.08.029. [DOI:10.1016/j.bcp.2018.08.029] [PMID]

48. Pierdomenico AM, Patruno S, Codagnone M, Simiele F, Mari VC, Plebani R, et al. microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A 4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. Sci Rep. 2017;7(1) :13519. doi: 10.1038/s41598-017-14055-y. [DOI:10.1038/s41598-017-14055-y] [PMID] [PMCID]

49. Sunkavalli U, Aguilar C, Silva RJ, Sharan M, Cruz AR, Tawk C, et al. Analysis of host microRNA function uncovers a role for miR-29b-2-5p in Shigella capture by filopodia. PLoS Pathog. 2017;13(4) :e1006327. doi: 10.1371/journal.ppat.1006327. [DOI:10.1371/journal.ppat.1006327] [PMID] [PMCID]

50. Nahand JS, Karimzadeh MR, Nezamnia M, Fatemipour M, Khatami A, Jamshidi S, et al. The role of miR-146a in viral infection. IUBMB life. 2020; 72(3): 343-60.doi: 10.1002/iub.2222. [DOI:10.1002/iub.2222] [PMID]

51. Mollaoglu G, Jones A, Wait S, Mukhopadhyay A, Jeong S, Arya R, et al. Abstract B72: Lineage specifiers SOX2 and NKX2-1 inversely regulate tumor cell fate and neutrophil recruitment in lung cancer. Cancer Immunology Research. 2020; 8(4_Supplement):B72.doi: 10.1158/2326-6074.TUMIMM18-B72. [DOI:10.1158/2326-6074.TUMIMM18-B72]

52. Yu H, Pang Z, Li G, Gu T. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer. J Clin Lab Anal. 2021;35(2):e23588. doi: 10.1002/jcla.23588. [DOI:10.1002/jcla.23588] [PMID] [PMCID]

53. Chen L, Gibbons DL, Goswami S, Cortez MA, Ahn YH, Byers LA, et al. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun. 2014;5:5241.doi: 10.1038/ncomms6241. [DOI:10.1038/ncomms6241] [PMID] [PMCID]

54. Ma ZL, Hou PP, Li YL, Wang DT, Yuan TW, Wei JL, et al. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2. Tumour Biol. 2015;36(4):2481-90. doi: 10.1007/s13277-014-2861-5. [DOI:10.1007/s13277-014-2861-5] [PMID]

55. Wu C, Cao Y, He Z, He J, Hu C, Duan H, et al. Serum Levels of miR-19b and miR-146a as Prognostic Biomarkers for Non-Small Cell Lung Cancer. Tohoku J Exp Med. 2014;232(2):85-95.doi: 10.1620/tjem.232.85. [DOI:10.1620/tjem.232.85] [PMID]

56. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15-20. doi: 10.1016/j.cell.2004.12.035. [DOI:10.1016/j.cell.2004.12.035] [PMID] [PMCID]

57. Rusca N, Monticelli S. MiR-146a in Immunity and Disease. Mol Biol Int. 2011; 2011: :437301. doi: 10.4061/2011/437301. [DOI:10.4061/2011/437301] [PMID] [PMCID]

58. Kolahi S, Farajzadeh MJ, Alipour S, Abhari A, Farhadi J, Bahavarnia N, et al. Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-α and CTLA4 genes in patients with Behcet's disease. Immunol Lett. 2018;204:55-9.doi: 10.1016/j.imlet.2018.10.012. [DOI:10.1016/j.imlet.2018.10.012] [PMID]

59. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, et al. Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses. Cell. 2010;142(6):914-29.doi: 10.1016/j.cell.2010.08.012. [DOI:10.1016/j.cell.2010.08.012] [PMID] [PMCID]

60. Jadideslam G, Ansarin K, Sakhinia E, Babaloo Z, Abhari A, Alipour S, et al. Expression levels of miR-21, miR-146b and miR-326 as potential biomarkers in Behcet's disease. Biomark Med. 2019;13(16):1339-48. doi: 10.2217/bmm-2019-0098. [DOI:10.2217/bmm-2019-0098] [PMID]

61. Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis CA. Immunologic mechanisms in asthma. Semin Immunol. 2019;46 :101333.doi: 10.1016/j.smim.2019.101333. [DOI:10.1016/j.smim.2019.101333] [PMID]

62. Traister RS, Wenzel SE. Inflammatory phenotypes in asthma pathogenesis. Drug Discovery Today: Disease Mechanisms. 2012;9(3-4):e75-81.doi: 10.1016/j.ddmec.2012.09.001. [DOI:10.1016/j.ddmec.2012.09.001]

63. Tliba O, Panettieri RA. Paucigranulocytic asthma: Uncoupling of airway obstruction from inflammation. J Allergy Clin Immunol. 2019;143(4):1287-94. doi: 10.1016/j.jaci.2018.06.008. [DOI:10.1016/j.jaci.2018.06.008] [PMID] [PMCID]

64. Taylor SL, Leong LEX, Choo JM, Wesselingh S, Yang IA, Upham JW, et al. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J Allergy Clin Immunol. 2018;141(1):94-103.e15. doi: 10.1016/j.jaci.2017.03.044. [DOI:10.1016/j.jaci.2017.03.044] [PMID] [PMCID]

65. Svenningsen S, Nair P. Asthma Endotypes and an Overview of Targeted Therapy for Asthma. Front Med. 2017;4(158). doi: 10.3389/fmed.2017.00158. [DOI:10.3389/fmed.2017.00158] [PMID] [PMCID]

66. Aleman F, Lim HF, Nair P. Eosinophilic Endotype of Asthma. Immunol Allergy Clin North Am. 2016;36(3):559-68.doi: 10.1016/j.iac.2016.03.006. [DOI:10.1016/j.iac.2016.03.006] [PMID]

67. Ntontsi P, Loukides S, Bakakos P, Kostikas K, Papatheodorou G, Papathanassiou E, et al. Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes. Allergy. 2017;72(11):1761-7. doi: 10.1111/all.13184. [DOI:10.1111/all.13184] [PMID]

68. Malmhäll C, Alawieh S, Lu Y, Sjöstrand M, Bossios A, Eldh M, et al. MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung. J Allergy Clin Immunol. 2014;133(5):1429-38, 1438.e1-7. doi: 10.1016/j.jaci.2013.11.008. [DOI:10.1016/j.jaci.2013.11.008] [PMID] [PMCID]

69. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180(5):388-95. doi: 10.1164/rccm.200903-0392OC. [DOI:10.1164/rccm.200903-0392OC] [PMID] [PMCID]

70. Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, et al. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm. 2015;2015:879783.doi: 10.1155/2015/879783. [DOI:10.1155/2015/879783] [PMID] [PMCID]

71. Priller J, Böttcher C. Patrolling monocytes sense peripheral infection and induce cytokine-mediated neuronal dysfunction. Nat Med. 2017;23(6):659-61. doi: 10.1038/nm.4349. [DOI:10.1038/nm.4349] [PMID]

72. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350-400.doi: 1016/S0140-6736(17)30879-6. [DOI:10.1016/S0140-6736(17)30879-6] [PMID]

73. Nakagome K, Bochkov YA, Ashraf S, Brockman-Schneider RA, Evans MD, Pasic TR, et al. Effects of rhinovirus species on viral replication and cytokine production. J Allergy Clin Immunol. 2014;134(2) :332-41. doi: 10.1016/j.jaci.2014.01.029. [DOI:10.1016/j.jaci.2014.01.029] [PMID] [PMCID]

74. Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH, et al. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012;11:71. doi: 10.1186/1476-4598-11-71. [DOI:10.1186/1476-4598-11-71] [PMID] [PMCID]

75. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481-6. doi: 10.1073/pnas.0605298103. [DOI:10.1073/pnas.0605298103] [PMID] [PMCID]

76. Kivihall A, Aab A, Soja J, Sładek K, Sanak M, Altraja A, et al. Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration. Clin Transl Allergy. 2019;9:62.doi: 10.1186/s13601-019-0301-8. [DOI:10.1186/s13601-019-0301-8] [PMID] [PMCID]

77. Rebane A, Runnel T, Aab A, Maslovskaja J, Rückert B, Zimmermann M, et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol. 2014;134(4):836-47.e11. doi: 10.1016/j.jaci.2014.05.022. [DOI:10.1016/j.jaci.2014.05.022] [PMID]

78. Han S, Ma C, Bao L, Lv L, Huang M. miR-146a Mimics Attenuate Allergic Airway Inflammation by Impacted Group 2 Innate Lymphoid Cells in an Ovalbumin-Induced Asthma Mouse Model. Int Arch Allergy Immunol. 2018;177(4):302-10. doi: 10.1159/000491438. [DOI:10.1159/000491438] [PMID]

79. Collison A, Herbert C, Siegle JS, Mattes J, Foster PS, Kumar RK. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm Med. 2011;11 :29. doi: 10.1186/1471-2466-11-29. [DOI:10.1186/1471-2466-11-29] [PMID] [PMCID]

80. Feng MJ, Shi F, Qiu C, Peng WK. MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma. Int Immunopharmacol. 2012;13(3):347-53. doi: 10.1016/j.intimp.2012.05.001. [DOI:10.1016/j.intimp.2012.05.001] [PMID]

81. Panganiban RP, Wang Y, Howrylak J, Chinchilli VM, Craig TJ, August A, et al. Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 2016;137(5):1423-32. doi: 10.1016/j.jaci.2016.01.029. [DOI:10.1016/j.jaci.2016.01.029] [PMID] [PMCID]

82. Rebane A, Akdis CA. MicroRNAs in allergy and asthma. Curr Allergy Asthma Rep. 2014;14(4):424. doi: 10.1007/s11882-014-0424-x. [DOI:10.1007/s11882-014-0424-x] [PMID]

83. Laanesoo A, Urgard E, Periyasamy K, Laan M, Bochkov YA, Aab A, et al. Dual role of the miR‐146 family in rhinovirus‐induced airway inflammation and allergic asthma exacerbation. Clin Transl Med. 2021;11(6) :e427. doi: 10.1002/ctm2.427. [DOI:10.1002/ctm2.427] [PMID] [PMCID]

84. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294(10):1255-9. doi: 10.1001/jama.294.10.1255. [DOI:10.1001/jama.294.10.1255] [PMID] [PMCID]

85. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341-51.doi: 10.1016/S0140-6736(11)60968-9. [DOI:10.1016/S0140-6736(11)60968-9] [PMID] [PMCID]

86. Sato T, Liu X, Nelson A, Nakanishi M, Kanaji N, Wang X, et al. Reduced miR-146a increases prostaglandin E₂in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2010;182(8):1020-9. doi: 10.1164/rccm.201001-0055OC. [DOI:10.1164/rccm.201001-0055OC] [PMID] [PMCID]

87. Van Pottelberge GR, Mestdagh P, Bracke KR, Thas O, Van Durme YMTA, Joos GF, et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(7):898-906. doi: 10.1164/rccm.201002-0304OC. [DOI:10.1164/rccm.201002-0304OC] [PMID] [PMCID]

88. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One. 2009;4(10) e7380. doi: 10.1371/journal.pone.0007380. [DOI:10.1371/journal.pone.0007380] [PMID] [PMCID]

89. Ezzie ME, Crawford M, Cho JH, Orellana R, Zhang S, Gelinas R, et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax. 2012;67(2):122-31.doi: 10.1136/thoraxjnl-2011-200089. [DOI:10.1136/thoraxjnl-2011-200089] [PMID]

90. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WDC, Moxham J, et al. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax. 2012;67(1):26-34. doi: 10.1136/thoraxjnl-2011-200309. [DOI:10.1136/thoraxjnl-2011-200309] [PMID] [PMCID]

91. Cillóniz C, Torres A, Niederman M, van der Eerden M, Chalmers J, Welte T, et al. Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med.2016; 42(9):1374-86. doi: 10.1007/s00134-016-4394-4. [DOI:10.1007/s00134-016-4394-4] [PMID]

92. Bartlett J. Treatment of community-acquired pneumonia. Chemotherapy. 2000;46(SUPPL 1):24-31.doi: 10.1159/000048489. [DOI:10.1159/000048489] [PMID]

93. Korppi M. Diagnosis and treatment of community-acquired pneumonia in children. Acta Paediatr. 2012;101(7):702-4. doi: 10.1111/j.1651-2227.2012.02648.x. [DOI:10.1111/j.1651-2227.2012.02648.x] [PMID]

94. Simonetti AF, Viasus D, Garcia Vidal C, Carratal J. Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis. 2014;2(1):3-16. doi: 10.1177/2049936113518041. [DOI:10.1177/2049936113518041] [PMID] [PMCID]

95. Wardlaw T, Salama P, Johansson EW, Mason E. Pneumonia: the leading killer of children. Lancet (London, England). 2006;368(9541):1048-50.doi: 1016/S0140-6736(06)69334-3. [DOI:10.1016/S0140-6736(06)69334-3] [PMID]

96. Comer BS, Camoretti-Mercado B, Kogut PC, Halayko AJ, Solway J, Gerthoffer WT. MicroRNA-146a and microRNA-146b expression and anti-inflammatory function in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2014;307(9):L727-34.doi: 10.1152/ajplung.00174.2014. [DOI:10.1152/ajplung.00174.2014] [PMID] [PMCID]

97. Ye EA, Steinle JJ. MiR-146a Attenuates Inflammatory Pathways Mediated by TLR4/NF- B and TNF α to Protect Primary Human Retinal Microvascular Endothelial Cells Grown in High Glucose. Mediators Inflamm. 2016;2016 :3958453.doi: 10.1155/2016/3958453. [DOI:10.1155/2016/3958453] [PMID] [PMCID]

98. Yang Y, Wu BQ, Wang YH, Shi YF, Luo JM, Ba JH, et al. Regulatory effects of miR-155 and miR-146a on repolarization and inflammatory cytokine secretion in human alveolar macrophages in vitro. mmunopharmacol Immunotoxicol. 2016;38(6):502-9.doi: 10.1080/08923973.2016.1248845. [DOI:10.1080/08923973.2016.1248845] [PMID]

99. Ramkaran P, Khan S, Phulukdaree A, Moodley D, Chuturgoon AA. miR-146a Polymorphism Influences Levels of miR-146a, IRAK-1, and TRAF-6 in Young Patients with Coronary Artery Disease. Cell Biochem Biophys. 2014;68(2):259-66.doi: 10.1007/s12013-013-9704-7. [DOI:10.1007/s12013-013-9704-7] [PMID]

100. Li HN, Zhao X, Zha YJ, Du F, Liu J, Sun L. MiR-146a-5p suppresses ATP-binding cassette subfamily G member 1 dysregulation in patients with refractory Mycoplasma pneumoniae via interleukin 1 receptor-associated kinase 1 downregulation. Int J Mol Med. 2019;44(6):2003-14. [GOOGLE SCHOLAR]

101. Lo WY, Peng CT, Wang HJ. MicroRNA-146a-5p Mediates High Glucose-Induced Endothelial Inflammation via Targeting Interleukin-1 Receptor-Associated Kinase 1 Expression. Front Physiol]. 2017; 8:551 .doi: 10.3389/fphys.2017.00551. [DOI:10.3389/fphys.2017.00551] [PMID] [PMCID]

102. Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017; 3:17074. doi: 10.1038/nrdp.2017.74. [DOI:10.1038/nrdp.2017.74] [PMID]

103. Luzina IG, Todd NW, Sundararajan S, Atamas SP. The cytokines of pulmonary fibrosis: Much learned, much more to learn. Cytokine. 2015;74(1):88-100.doi: 10.1016/j.cyto.2014.11.008. [DOI:10.1016/j.cyto.2014.11.008] [PMID]

104. Mora AL, Rojas M, Pardo A, Selman M. Erratum: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease. Nat Rev Drug Discov .2017; 16(11):810doi: 10.1038/nrd.2017.225. [DOI:10.1038/nrd.2017.225] [PMID] [PMCID]

105. Barlo NP, Van Moorsel CHM, Korthagen NM, Heron M, Rijkers GT, Ruven HJT, et al. Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis. Clin Exp Immunol. 2011;166(3):346-51. doi: 10.1111/j.1365-2249.2011.04468.x. [DOI:10.1111/j.1365-2249.2011.04468.x] [PMID] [PMCID]

106. Kähäri VM, Heino J, Vuorio E. Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim Biophys Acta. 1987;929(2):142-7.doi: 10.1016/0167-4889(87)90169-8. [DOI:10.1016/0167-4889(87)90169-8]

107. Miyazawa K, Mori A, Miyata H, Akahane M, Ajisawa Y, Okudaira H. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J Biol Chem. 1998;273(38):24832-8.doi: 10.1074/jbc.273.38.24832. [DOI:10.1074/jbc.273.38.24832] [PMID]

108. Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol. 2016;16(5):279-94.doi: 10.1038/nri.2016.40. [DOI:10.1038/nri.2016.40] [PMID]

109. Lindsay MA. microRNAs and the immune response. Trends Immunol. 2008;29(7):343-51.doi: 10.1016/j.it.2008.04.004. [DOI:10.1016/j.it.2008.04.004] [PMID] [PMCID]

110. O'Connell RM, Rao DS, Baltimore D. microRNA Regulation of Inflammatory Responses. annurev-immunol-020711-075013. 2012;30:295-312.doi: 10.1146/annurev-immunol-020711-075013. [DOI:10.1146/annurev-immunol-020711-075013] [PMID]

111. Kopp F, Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018;172(3):393-407.doi: 10.1016/j.cell.2018.01.011. [DOI:10.1016/j.cell.2018.01.011] [PMID] [PMCID]

112. Delás MJ, Hannon GJ. lncRNAs in development and disease: from functions to mechanisms. Open Biol. 2017;7(7) :170121.doi: 10.1098/rsob.170121. [DOI:10.1098/rsob.170121] [PMID] [PMCID]

113. Rinn JL, Chang HY. Genome Regulation by Long Noncoding RNAs. Annu Rev Biochem .2012;81:145-66.doi: 10.1146/annurev-biochem-051410-092902. [DOI:10.1146/annurev-biochem-051410-092902] [PMID] [PMCID]

114. Heward JA, Lindsay MA. Long non-coding RNAs in the regulation of the immune response. Trends Immunol. 2014;35(9):408-19.doi: 10.1016/j.it.2014.07.005. [DOI:10.1016/j.it.2014.07.005] [PMID] [PMCID]

115. Krawczyk M, Emerson BM. P50-associated COX-2 Extragenic RNA (pacer) activates human COX-2 gene expression by occluding repressive NF-κB p50 complexes. Elife. 2014;(3):e01776.doi: 10.7554/eLife.01776. [DOI:10.7554/eLife.01776] [PMID] [PMCID]

116. Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C, et al. The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A. 2014;111(3):1002-7.doi: 10.1073/pnas.1313768111. [DOI:10.1073/pnas.1313768111] [PMID] [PMCID]

117. Iiott NE, Heward JA, Roux B, Tsitsiou E, Fenwick PS, Lenzi L, et al. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nat Commun.2014;5:3979.doi: 10.1038/ncomms4979. [DOI:10.1038/ncomms4979] [PMID] [PMCID]

118. Cui H, Xie N, Tan Z, Banerjee S, Thannickal VJ, Abraham E, et al. The human long noncoding RNA lnc-IL7R regulates the inflammatory response. Eur J Immunol. 2014;44(7):2085-95.doi: 10.1002/eji.201344126. [DOI:10.1002/eji.201344126] [PMID] [PMCID]

119. Atianand MK, Hu W, Satpathy AT, Shen Y, Ricci EP, Alvarez-Dominguez JR, et al. A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain Inflammation. Cell. 2016;165(7):1672-85.doi: 10.1016/j.cell.2016.05.075. [DOI:10.1016/j.cell.2016.05.075] [PMID] [PMCID]

120. Roux BT, Heward JA, Donnelly LE, Jones SW, Lindsay MA. Catalog of Differentially expressed long non-coding RNA following activation of human and mouse innate immune response. Front Immunol. 2017;8 :1038:doi: 10.3389/fimmu.2017.01038. [DOI:10.3389/fimmu.2017.01038] [PMID] [PMCID]

121. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009; 458(7235):223-7.doi: 10.1038/nature07672. [DOI:10.1038/nature07672] [PMID] [PMCID]

122. Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL, et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science.2013;341(6147):789-92.doi: 10.1126/science.1240925. [DOI:10.1126/science.1240925] [PMID] [PMCID]

123. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF- kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(33):12481-6.doi: 10.1073/pnas.0605298103. [DOI:10.1073/pnas.0605298103] [PMID] [PMCID]

124. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1β-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells. J Immunol. 2008;180(8):5689-98.doi: 10.4049/jimmunol.180.8.5689. [DOI:10.4049/jimmunol.180.8.5689] [PMID] [PMCID]

125. Hadjicharalambous MR, Roux BT, Feghali-Bostwick CA, Murray LA, Clarke DL, Lindsay MA. Long Non-coding RNAs Are Central Regulators of the IL-1β-Induced Inflammatory Response in Normal and Idiopathic Pulmonary Lung Fibroblasts. Front Immunol. 2018;9:2906. doi: 10.3389/fimmu.2018.02906. [DOI:10.3389/fimmu.2018.02906] [PMID] [PMCID]

126. Shahriar A, Ghale-aziz Shiva G, Ghader B, Farhad J, Hosein A, Parsa H. The dual role of mir-146a in metastasis and disease progression. Biomed Pharmacother. 2020;126 :110099. doi: 10.1016/j.biopha.2020.110099. [DOI:10.1016/j.biopha.2020.110099] [PMID]

127. Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, et al. miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells. PLoS One. 2013;8(3):e60317.doi: 10.1371/journal.pone.0060317. [DOI:10.1371/journal.pone.0060317] [PMID] [PMCID]

128. Bertoli G, Cava C, Castiglioni I. Micrornas: New biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122-43.doi: 10.7150/thno.11543. [DOI:10.7150/thno.11543] [PMID] [PMCID]

129. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell . 2011;144(5):646-74. doi: 10.1016/j.cell.2011.02.013. [DOI:10.1016/j.cell.2011.02.013] [PMID]

130. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704-15.doi: 10.1016/j.cell.2008.03.027. [DOI:10.1016/j.cell.2008.03.027] [PMID] [PMCID]

131. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741-51. doi: 10.1038/onc.2010.215. [DOI:10.1038/onc.2010.215] [PMID] [PMCID]

132. Mitchell S, Vargas J, Hoffmann A. Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med. 2016;8(3):227-41. doi: 10.1002/wsbm.1331. [DOI:10.1002/wsbm.1331] [PMID] [PMCID]

133. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF- kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481-6.doi: 10.1073/pnas.0605298103. [DOI:10.1073/pnas.0605298103] [PMID] [PMCID]

134. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology. 2020;146(1):110-8. doi: 10.1016/j.jaci.2020.04.006. [DOI:10.1016/j.jaci.2020.04.006] [PMID] [PMCID]

135. Liu Z, Wang J, Xu Y, Guo M, Mi K, Xu R, et al. Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2 [Internet]. arXiv; 2020 [cited 2026 Jul 20]. Available from: http://arxiv.org/abs/2004.04874 doi:10.48550/arXiv.2004.04874 [GOOGLE SCHOLAR]

136. Trobaugh DW, Klimstra WB. MicroRNA Regulation of RNA Virus Replication and Pathogenesis. Trends Mol Med. 2017;23(1):80-93.doi: 10.1016/j.molmed.2016.11.003. [DOI:10.1016/j.molmed.2016.11.003] [PMID] [PMCID]

137. Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li X, et al. Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a via Targeting the NF-κB Signaling Pathway. Front Immunol. 2018; 9:293.doi: 10.3389/fimmu.2018.00293. [DOI:10.3389/fimmu.2018.00293] [PMID] [PMCID]

138. Xu D, Han Q, Hou Z, Zhang C, Zhang J. miR-146a negatively regulates NK cell functions via STAT1 signaling. Cell Mol Immunol 2016 148. 2017;14(8):712-20.doi: 10.1038/cmi.2015.113. [DOI:10.1038/cmi.2015.113] [PMID] [PMCID]

139. Masselli E, Vaccarezza M, Carubbi C, Pozzi G, Presta V, Mirandola P, et al. NK cells: A double edge sword against SARS-CoV-2. Adv Biol Regul. 2020;77:100737.doi: 10.1016/j.jbior.2020.100737. [DOI:10.1016/j.jbior.2020.100737] [PMID] [PMCID]

140. Sinha P, Matthay MA, Calfee CS. Is a "Cytokine Storm" Relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152-4.doi: 10.1001/jamainternmed.2020.3313. [DOI:10.1001/jamainternmed.2020.3313] [PMID] [PMCID]

141. Teymoori-Rad M, Mozhgani SH, Zarei-Ghobadi M, Sahraian MA, Nejati A, Amiri MM, et al. Integrational analysis of miRNAs data sets as a plausible missing linker between Epstein-Barr virus and vitamin D in relapsing remitting MS patients. Gene. 2019;689:1-10.doi: 10.1016/j.gene.2018.12.004. [DOI:10.1016/j.gene.2018.12.004] [PMID]

142. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain. 2009;132(pt12):3342-52.doi: 10.1093/brain/awp300. [DOI:10.1093/brain/awp300] [PMID]

143. Mensà E, Recchioni R, Marcheselli F, Giuliodori K, Consales V, Molinelli E, et al. MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab. Br J Dermatol. 2018;179(3):787-9.doi: 10.1111/bjd.16659. [DOI:10.1111/bjd.16659] [PMID]

144. García-Rodríguez S, Arias-Santiago S, Blasco-Morente G, Orgaz-Molina J, Rosal-Vela A, Navarro P, et al. Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity. J Eur Acad Dermatology Venereol. 2017;31(2):312-22. doi: 10.1111/jdv.13861. [DOI:10.1111/jdv.13861] [PMID]

145. Hermann H, Runnel T, Aab A, Baurecht H, Rodriguez E, Magilnick N, et al. miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis. J Invest Dermatol. 2017;137(9):1945-54.doi: 10.1016/j.jid.2017.05.012. [DOI:10.1016/j.jid.2017.05.012] [PMID] [PMCID]

146. Zibert JR, Løvendorf MB, Litman T, Olsen J, Kaczkowski B, Skov L. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci. 2010;58(3):177-85.doi: 10.1016/j.jdermsci.2010.03.004. [DOI:10.1016/j.jdermsci.2010.03.004] [PMID] [PMCID]

147. Sonkoly E, Wei T, Janson PCJ, Sääf A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis? PLoS One. 2007;2(7):e610.doi: 10.1371/journal.pone.0000610. [DOI:10.1371/journal.pone.0000610] [PMID] [PMCID]

148. Xia P, Fang X, Zhang ZH, Huang Q, Yan KX, Kang KF, et al. Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett. 2012;148(2):151-62.doi: 10.1016/j.imlet.2012.09.004. [DOI:10.1016/j.imlet.2012.09.004] [PMID]

149. Bernecker C, Lenz L, Ostapczuk MS, Schinner S, Willenberg H, Ehlers M, et al. MicroRNAs miR-146a1, miR-155_2, and miR-200a1 are regulated in autoimmune thyroid diseases. Thyroid. 2012;22(12):1294-5.doi: 10.1089/thy.2012.0277. [DOI:10.1089/thy.2012.0277] [PMID]

150. Wei H, Guan M, Qin Y, Xie C, Fu X, Gao F, et al. Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy. Endocr J. 2014;61(11):1087-92.doi: 10.1507/endocrj.EJ14-0246. [DOI:10.1507/endocrj.EJ14-0246] [PMID]

151. Yang WJ, Ma PF, Li SP, Su H, Liu YJ. MicroRNA-146a contributes to CD4+ T lymphocyte differentiation in patients with thyroid ophthalmopathy. Am J Transl Res. 2017;9(4):1801-9. [GOOGLE SCHOLAR]

152. Jang SY, Park SJ, Chae MK, Lee JH, Lee EJ, Yoon JS. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy. Br J Ophthalmol. 2018;102(3):407-14.doi: 10.1136/bjophthalmol-2017-310723. [DOI:10.1136/bjophthalmol-2017-310723] [PMID]

153. Chen JQ, Papp G, Póliska S, Szabó K, Tarr T, Bálint BL, et al. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome. PLoS One. 2017;12(3):e0174585.doi: 10.1371/journal.pone.0174585. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174585 [DOI:10.1371/journal.pone.0174585] [PMID] [PMCID]

154. Zilahi E, Tarr T, Papp G, Griger Z, Sipka S, Zeher M. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome. Immunol Lett. 2012;141(2):165-8.doi: 10.1016/j.imlet.2011.09.006. [DOI:10.1016/j.imlet.2011.09.006] [PMID]

155. Wang-Renault SF, Boudaoud S, Nocturne G, Roche E, Sigrist N, Daviaud C, et al. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome. Ann Rheum Dis. 2018;77(1):133-40. doi: 10.1136/annrheumdis-2017-211417. [DOI:10.1136/annrheumdis-2017-211417] [PMID] [PMCID]

156. Gauna AE, Park YJ, Nayar G, Onate M, Jin JO, Stewart CM, et al. Dysregulated co-stimulatory molecule expression in a Sjögren's syndrome mouse model with potential implications by microRNA-146a. Mol Immunol. 2015;68(2):606-16.doi: 10.1016/j.molimm.2015.09.027. [DOI:10.1016/j.molimm.2015.09.027] [PMID] [PMCID]

157. Pauley KM, Stewart CM, Gauna AE, Dupre LC, Kuklani R, Chan AL, et al. Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Eur J Immunol. 2011;41(7):2029-39.doi: 10.1002/eji.201040757. [DOI:10.1002/eji.201040757] [PMID] [PMCID]

158. Yousefzadeh N, Alipour MR, Ghadiri Soufi FG. Deregulation of NF-кB-miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy. J Physiol Biochem 2015;71(1):51-8.doi: 10.1007/s13105-014-0378-4. [DOI:10.1007/s13105-014-0378-4] [PMID]

159. Chen S, Feng B, Thomas AA, Chakrabarti S. miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes. PLoS One. 2017;12(3):e0173918.doi: 10.1371/journal.pone.0173918. [DOI:10.1371/journal.pone.0173918] [PMID] [PMCID]

160. Wang Q, Bozack SN, Yan Y, Boulton ME, Grant MB, Busik J V. Regulation of Retinal Inflammation by Rhythmic Expression of MiR-146a in Diabetic Retina. Invest Ophthalmol Vis Sci. 2014;55(6):3986-94.doi: 10.1167/iovs.13-13076. [DOI:10.1167/iovs.13-13076] [PMID] [PMCID]

161. Gong Q, Xie J, Liu Y, Li Y, Su G. Differentially Expressed MicroRNAs in the Development of Early Diabetic Retinopathy. J Diabetes Res. 2017; 2017(1):4727942.doi: 10.1155/2017/4727942. [DOI:10.1155/2017/4727942] [PMID] [PMCID]

162. Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, et al. miR-146a-Mediated Extracellular Matrix Protein Production in Chronic Diabetes Complications. Diabetes. 2011;60(11):2975-84. doi: 10.2337/db11-0478. [DOI:10.2337/db11-0478] [PMID] [PMCID]

163. Prajzlerová K, Grobelná K, Hušáková M, Forejtová Š, Jüngel A, Gay S, et al. Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis. PLoS One. 2017;12(9):e0185323. doi: 10.1371/journal.pone.0185323. [DOI:10.1371/journal.pone.0185323] [PMID] [PMCID]

164. Hammad Mahmoud Hammad R, Hamed DHED, Eldosoky MAER, Ahmad AAES, Osman HM, Abd Elgalil HM, et al. Plasma microRNA-21, microRNA-146a and IL-13 expression in asthmatic children. Innate Immun. 2018;24(3):171-9. doi: 10.1177/1753425918763521. [DOI:10.1177/1753425918763521] [PMID] [PMCID]

165. Weidner H, Mez L, Okamura L. Introduction and Research Approach. InThe Ecological Modernization Capacity of Japan and Germany: Comparing Nuclear Energy, Renewables, Automobility and Rare Earth Policy. 2020;1-12.doi: 10.1007/978-3-658-27405-4_1. [DOI:10.1007/978-3-658-27405-4_1] [PMCID]

166. Panganiban RP, Wang Y, Howrylak J, Chinchilli VM, Craig TJ, August A, et al. Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 2016;137(5):1423-32.doi: 10.1016/j.jaci.2016.01.029. [DOI:10.1016/j.jaci.2016.01.029] [PMID] [PMCID]

167. Faiz A, Weckmann M, Tasena H, Vermeulen CJ, Van Den Berge M, Ten Hacken NHT, et al. Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1β treatment: a novel role for CCL20 in chronic mucus hypersecretion. Eur Respir J. 2018;52(2). :1800310.doi: 10.1183/13993003.00310-2018. [DOI:10.1183/13993003.00310-2018] [PMID]

168. Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE, Adcock IM, et al. MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy. PLoS One. 2009;4(6):e5889.doi: 10.1371/journal.pone.0005889. [DOI:10.1371/journal.pone.0005889] [PMID] [PMCID]

169. Singh A, Patro PS, Aggarwal A. MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38(3):877-84.doi: 10.1007/s10067-018-4380-z. [DOI:10.1007/s10067-018-4380-z] [PMID]

170. Zhou Q, Haupt S, Kreuzer JT, Hammitzsch A, Proft F, Neumann C, et al. Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis. Ann Rheum Dis. 2015;74(6):1265-74.doi: 10.1136/annrheumdis-2013-204377. [DOI:10.1136/annrheumdis-2013-204377] [PMID]

171. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EKL. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther. 2008;10(4): R101.doi: 10.1186/ar2493. [DOI:10.1186/ar2493] [PMID] [PMCID]

172. Li J, Wan Y, Guo Q, Zou L, Zhang J, Fang Y, et al. Altered microRNA expression profile with miR-146a upregulation in CD4+T cells from patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12(3):1-12 :R81.doi: 10.1186/ar3006. [DOI:10.1186/ar3006] [PMID] [PMCID]

173. Chatzikyriakidou A, Voulgari P V, Georgiou I, Drosos AA. A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine. 2010;77(5):411-3.doi: 10.1016/j.jbspin.2010.05.013. [DOI:10.1016/j.jbspin.2010.05.013] [PMID]

174. Stanczyk J, Leslie Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):1001-9. doi:10.1002/art.23386. [DOI:10.1002/art.23386] [PMID]

175. Takahashi Y, Haga S, Ishizaka Y, Mimori A. Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Arthritis Res Ther. 2010;12(3) :R85.doi: 10.1186/ar3012. [DOI:10.1186/ar3012] [PMID] [PMCID]

176. Zhou Q, Haupt S, Kreuzer JT, Hammitzsch A, Proft F, Neumann C, et al. Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis. Ann Rheum Dis. 2015;74(6):1265-74.doi: 10.1136/annrheumdis-2013-204377. [DOI:10.1136/annrheumdis-2013-204377] [PMID]

177. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481-6.doi: 10.1073/pnas.0605298103. [DOI:10.1073/pnas.0605298103] [PMID] [PMCID]

178. Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med.2010;16(1):49-58.doi: 10.1038/nm.2054. [DOI:10.1038/nm.2054] [PMID]

179. Liu R, Liu C, Chen D, Yang WH, Liu X, Liu CG, et al. FOXP3 controls an MIR-146/NF-κB negative feedback loop that inhibits apoptosis in breast cancer cells. Cancer Res. 2015;75(8):1703-13. doi: 10.1158/0008-5472.CAN-14-2108. [DOI:10.1158/0008-5472.CAN-14-2108] [PMID] [PMCID]

180. Takahashi Y, Satoh M, Minami Y, Tabuchi T, Itoh T, Nakamura M. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Clin Sci (Lond). 2010;119(9):395-405.doi: 10.1042/CS20100003. [DOI:10.1042/CS20100003] [PMID]

181. Raitoharju E, Lyytikäinen LP, Levula M, Oksala N, Mennander A, Tarkka M, et al. MiR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis. 2011;219(1):211-7.doi: 10.1016/j.atherosclerosis.2011.07.020. [DOI:10.1016/j.atherosclerosis.2011.07.020] [PMID]

182. Gao M, Wang X, Zhang X, Ha T, Ma H, Liu L, et al. Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression. J Immunol. 2015;195(2):672-82.doi: 10.4049/jimmunol.1403155. [DOI:10.4049/jimmunol.1403155] [PMID] [PMCID]

183. Li JW, He SY, Feng ZZ, Zhao L, Jia WK, Liu P, et al. MicroRNA-146b inhibition augments hypoxia-induced cardiomyocyte apoptosis. Mol Med Rep. 2015;12(5):6903-10.doi: 10.3892/mmr.2015.4333. [DOI:10.3892/mmr.2015.4333] [PMID]

Send email to the article author

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 All Rights Reserved | Health Science Monitor | Designed & Developed by : Yektaweb